Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Comprehensive Target Engagement by the EZH2 Inhibitor Tul... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers
0
Authors
Patricia Keller
27 more
Patricia Keller
•
Elizabeth Adams
25 more
•
Patrick Trojer
Published
June 4, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Research
Topics
Biology
Cancer Oncology
Medicine
Paleontology
Internal Medicine
Show all topics
DOI
10.1158/0008-5472.can-24-0398
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Research
Topics
Biology
Cancer Oncology
Medicine
Paleontology
Internal Medicine
Show all topics
DOI
10.1158/0008-5472.can-24-0398
License
CC-BY-NC-ND
Other Formats
PDF
